Obesity, Metabolic Health, and Diabetic Complications in People With Type 1 Diabetes
ABSTRACT Aim The concept of metabolically healthy obesity (MHO) has not been studied in type 1 diabetes (T1D). By analysing datasets from the DCCT/EDIC study, we compared the development of diabetic complications by obesity and metabolic health over 30 years of follow up. Materials and Methods Insul...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Endocrinology, Diabetes & Metabolism |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/edm2.70017 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832586374449987584 |
|---|---|
| author | Yuanjie Mao Jen‐Tzer Gau Ning Jiang |
| author_facet | Yuanjie Mao Jen‐Tzer Gau Ning Jiang |
| author_sort | Yuanjie Mao |
| collection | DOAJ |
| description | ABSTRACT Aim The concept of metabolically healthy obesity (MHO) has not been studied in type 1 diabetes (T1D). By analysing datasets from the DCCT/EDIC study, we compared the development of diabetic complications by obesity and metabolic health over 30 years of follow up. Materials and Methods Insulin resistance was calculated by estimated glucose disposal rate (eGDR). The participants (n = 1127) were then divided into four groups based on time‐weighted mean body mass index and mean eGDR: metabolically healthy non‐obesity (MHN, n = 874), metabolically unhealthy non‐obesity (MUN, n = 66), MHO (n = 146) and metabolically unhealthy obesity (MUO, n = 41). Diabetic complications and cardiovascular events were compared across the four groups. Results MUO and MUN groups had significantly higher risk for peripheral neuropathy (p = 0.001 in MUO and p < 0.001 in MUN vs. MHN), cardiac autonomic neuropathy (p < 0.001 in both MUO and MUN vs. MHN), retinopathy (p = 0.001 in MUO and p < 0.001 in MUN vs. MHN) and microalbuminuria (p < 0.001 in both MUO and MUN vs. MHN) than MHN group. Moreover, MUO and MUN groups had significantly higher risks (HR [95%CI]) in any cardiovascular events (2.78 [1.51–5.11] and 1.88 [1.05–3.36]) and major atherosclerotic cardiovascular events (2.72 [1.16–6.37] and 2.31 [1.05–5.10]) compared to MHN group. However, the risk of these complications and cardiovascular events (except peripheral neuropathy and cardiac autonomic neuropathy) in MHO group was not different from that in MHN group. Conclusions This study highlights the importance of metabolic health represented by insulin resistance in the development of diabetic complications and cardiovascular events in T1D beyond their weight status. |
| format | Article |
| id | doaj-art-da46b616ef74430896286aa17f190f0d |
| institution | Kabale University |
| issn | 2398-9238 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Endocrinology, Diabetes & Metabolism |
| spelling | doaj-art-da46b616ef74430896286aa17f190f0d2025-01-25T18:20:28ZengWileyEndocrinology, Diabetes & Metabolism2398-92382025-01-0181n/an/a10.1002/edm2.70017Obesity, Metabolic Health, and Diabetic Complications in People With Type 1 DiabetesYuanjie Mao0Jen‐Tzer Gau1Ning Jiang2Diabetes Institute Ohio University Athens Ohio USADepartment of Primary Care, Heritage College of Osteopathic Medicine Ohio University Athens Ohio USACardiology Clinic LifeBridge Health Cardiovascular Institute Westminster Maryland USAABSTRACT Aim The concept of metabolically healthy obesity (MHO) has not been studied in type 1 diabetes (T1D). By analysing datasets from the DCCT/EDIC study, we compared the development of diabetic complications by obesity and metabolic health over 30 years of follow up. Materials and Methods Insulin resistance was calculated by estimated glucose disposal rate (eGDR). The participants (n = 1127) were then divided into four groups based on time‐weighted mean body mass index and mean eGDR: metabolically healthy non‐obesity (MHN, n = 874), metabolically unhealthy non‐obesity (MUN, n = 66), MHO (n = 146) and metabolically unhealthy obesity (MUO, n = 41). Diabetic complications and cardiovascular events were compared across the four groups. Results MUO and MUN groups had significantly higher risk for peripheral neuropathy (p = 0.001 in MUO and p < 0.001 in MUN vs. MHN), cardiac autonomic neuropathy (p < 0.001 in both MUO and MUN vs. MHN), retinopathy (p = 0.001 in MUO and p < 0.001 in MUN vs. MHN) and microalbuminuria (p < 0.001 in both MUO and MUN vs. MHN) than MHN group. Moreover, MUO and MUN groups had significantly higher risks (HR [95%CI]) in any cardiovascular events (2.78 [1.51–5.11] and 1.88 [1.05–3.36]) and major atherosclerotic cardiovascular events (2.72 [1.16–6.37] and 2.31 [1.05–5.10]) compared to MHN group. However, the risk of these complications and cardiovascular events (except peripheral neuropathy and cardiac autonomic neuropathy) in MHO group was not different from that in MHN group. Conclusions This study highlights the importance of metabolic health represented by insulin resistance in the development of diabetic complications and cardiovascular events in T1D beyond their weight status.https://doi.org/10.1002/edm2.70017cardiovascular eventscomplicationsmetabolic healthobesitytype 1 diabetes mellitus |
| spellingShingle | Yuanjie Mao Jen‐Tzer Gau Ning Jiang Obesity, Metabolic Health, and Diabetic Complications in People With Type 1 Diabetes Endocrinology, Diabetes & Metabolism cardiovascular events complications metabolic health obesity type 1 diabetes mellitus |
| title | Obesity, Metabolic Health, and Diabetic Complications in People With Type 1 Diabetes |
| title_full | Obesity, Metabolic Health, and Diabetic Complications in People With Type 1 Diabetes |
| title_fullStr | Obesity, Metabolic Health, and Diabetic Complications in People With Type 1 Diabetes |
| title_full_unstemmed | Obesity, Metabolic Health, and Diabetic Complications in People With Type 1 Diabetes |
| title_short | Obesity, Metabolic Health, and Diabetic Complications in People With Type 1 Diabetes |
| title_sort | obesity metabolic health and diabetic complications in people with type 1 diabetes |
| topic | cardiovascular events complications metabolic health obesity type 1 diabetes mellitus |
| url | https://doi.org/10.1002/edm2.70017 |
| work_keys_str_mv | AT yuanjiemao obesitymetabolichealthanddiabeticcomplicationsinpeoplewithtype1diabetes AT jentzergau obesitymetabolichealthanddiabeticcomplicationsinpeoplewithtype1diabetes AT ningjiang obesitymetabolichealthanddiabeticcomplicationsinpeoplewithtype1diabetes |